These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25117008)

  • 1. In vitro biological characterization of IFN-β-1a major glycoforms.
    Mastrangeli R; Rossi M; Mascia M; Palinsky W; Datola A; Terlizzese M; Bierau H
    Glycobiology; 2015 Jan; 25(1):21-9. PubMed ID: 25117008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).
    Runkel L; Meier W; Pepinsky RB; Karpusas M; Whitty A; Kimball K; Brickelmaier M; Muldowney C; Jones W; Goelz SE
    Pharm Res; 1998 Apr; 15(4):641-9. PubMed ID: 9587963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
    Meager A; Das RG
    J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological Functions of Interferon β-1a Are Enhanced By Deamidation.
    Mastrangeli R; Iozzino L; Lanzoni L; Angiuoni G; Ferrao C; Izzo A; Fiumi S; Camerini F; Mascia M; Palinsky W; Bierau H
    J Interferon Cytokine Res; 2016 Sep; 36(9):534-41. PubMed ID: 27348209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, purification, and characterization of rat interferon-beta, and preparation of an N-terminally PEGylated form with improved pharmacokinetic parameters.
    Arduini RM; Li Z; Rapoza A; Gronke R; Hess DM; Wen D; Miatkowski K; Coots C; Kaffashan A; Viseux N; Delaney J; Domon B; Young CN; Boynton R; Chen LL; Chen L; Betzenhauser M; Miller S; Gill A; Pepinsky RB; Hochman PS; Baker DP
    Protein Expr Purif; 2004 Apr; 34(2):229-42. PubMed ID: 15003256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of N-Acetylcystein on butyrate-treated Chinese hamster ovary cells to improve the production of recombinant human interferon-beta-1a.
    Oh HK; So MK; Yang J; Yoon HC; Ahn JS; Lee JM; Kim JT; Yoo JU; Byun TH
    Biotechnol Prog; 2005; 21(4):1154-64. PubMed ID: 16080696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation.
    Yin B; Gao Y; Chung CY; Yang S; Blake E; Stuczynski MC; Tang J; Kildegaard HF; Andersen MR; Zhang H; Betenbaugh MJ
    Biotechnol Bioeng; 2015 Nov; 112(11):2343-51. PubMed ID: 26154505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-glycan structures and N-glycosylation sites of mouse soluble intercellular adhesion molecule-1 revealed by MALDI-TOF and FTICR mass spectrometry.
    Otto VI; Damoc E; Cueni LN; Schürpf T; Frei R; Ali S; Callewaert N; Moise A; Leary JA; Folkers G; Przybylski M
    Glycobiology; 2006 Nov; 16(11):1033-44. PubMed ID: 16877748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing recombinant glycoprotein sialylation through CMP-sialic acid transporter over expression in Chinese hamster ovary cells.
    Wong NS; Yap MG; Wang DI
    Biotechnol Bioeng; 2006 Apr; 93(5):1005-16. PubMed ID: 16432895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring recombinant human interferon-gamma N-glycosylation during perfused fluidized-bed and stirred-tank batch culture of CHO cells.
    Goldman MH; James DC; Rendall M; Ison AP; Hoare M; Bull AT
    Biotechnol Bioeng; 1998 Dec; 60(5):596-607. PubMed ID: 10099468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and antivirus activities of a novel bovine IFN-omega24.
    Luo X; Guo Y; Bao J; Liu Y; An D; Ma B; Gao M; Wang J
    Mol Immunol; 2015 Aug; 66(2):357-63. PubMed ID: 25951414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation of human recombinant gonadotrophins: characterization and batch-to-batch consistency.
    Gervais A; Hammel YA; Pelloux S; Lepage P; Baer G; Carte N; Sorokine O; Strub JM; Koerner R; Leize E; Van Dorsselaer A
    Glycobiology; 2003 Mar; 13(3):179-89. PubMed ID: 12626416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of recombinant human thyrotropin (TSH) isoforms produced by Chinese hamster ovary cells: the role of sialylation and sulfation in TSH bioactivity.
    Szkudlinski MW; Thotakura NR; Bucci I; Joshi LR; Tsai A; East-Palmer J; Shiloach J; Weintraub BD
    Endocrinology; 1993 Oct; 133(4):1490-503. PubMed ID: 8404588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production, purification, and characterization of recombinant hFSH glycoforms for functional studies.
    Butnev VY; Butnev VY; May JV; Shuai B; Tran P; White WK; Brown A; Smalter Hall A; Harvey DJ; Bousfield GR
    Mol Cell Endocrinol; 2015 Apr; 405():42-51. PubMed ID: 25661536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of bisected glycoforms of recombinant IFN-beta by overexpression of beta-1,4-N-acetylglucosaminyltransferase III in Chinese hamster ovary cells.
    Sburlati AR; Umaña P; Prati EG; Bailey JE
    Biotechnol Prog; 1998; 14(2):189-92. PubMed ID: 9548768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the understanding of biological implications and modulation methodologies of monoclonal antibody N-linked high mannose glycans.
    Shi HH; Goudar CT
    Biotechnol Bioeng; 2014 Oct; 111(10):1907-19. PubMed ID: 24975601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ammonia and glucosamine on the heterogeneity of erythropoietin glycoforms.
    Yang M; Butler M
    Biotechnol Prog; 2002; 18(1):129-38. PubMed ID: 11822911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constraints on the transport and glycosylation of recombinant IFN-gamma in Chinese hamster ovary and insect cells.
    Hooker AD; Green NH; Baines AJ; Bull AT; Jenkins N; Strange PG; James DC
    Biotechnol Bioeng; 1999 Jun; 63(5):559-72. PubMed ID: 10397812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycan analysis of glycoprotein pharmaceuticals: Evaluation of analytical approaches to Z number determination in pharmaceutical erythropoietin products.
    Yuen CT; Zhou Y; Wang QZ; Hou JF; Bristow A; Wang JZ
    Biologicals; 2011 Nov; 39(6):396-403. PubMed ID: 21993307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylation and antiproliferative activity of hyperglycosylated IFN-α2 potentiate HEK293 cells as biofactories.
    Gugliotta A; Ceaglio N; Raud B; Forno G; Mauro L; Kratje R; Oggero M
    Eur J Pharm Biopharm; 2017 Mar; 112():119-131. PubMed ID: 27867113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.